Get started
GLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD (GBP) AGLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD (GBP) AGLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD (GBP) A

GLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD (GBP) A

No trades
See on Supercharts
Overview
Analysis
Holdings Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪5.40 M‬ GBP
Fund flows (1Y)
‪2.55 M‬ GBP
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.4%
Shares outstanding
‪1.01 M‬
Expense ratio
0.60%

About GLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD (GBP) A


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Home page
globalxetfs.eu
Inception date
Nov 2, 2021
Index tracked
Solactive Genomics v2 Index - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Carne Global Fund Managers (Ireland) Ltd.
ISIN
IE00BM8R0N95
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index

Classification


Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of April 16, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.95%
Health Technology98.98%
Health Services0.98%
Bonds, Cash & Other0.05%
Cash0.05%
Miscellaneous0.00%
Stock breakdown by region
79%16%3%
North America79.89%
Europe16.29%
Asia3.82%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows